PitchBook’s Q1 2024 Biopharma Report

Developing a cure for cancer is a holy grail of biopharmaceutical research—and some clinical trials have begun to show promising signs, according to PitchBook’s Q1 2024 Biopharma Report. Drug researchers are incorporating new technologies like mRNA into vaccine development. As well as the major partnerships between pharma and biotech, like Moderna’s collaboration with Merck, some venture-backed companies are quietly making notable strides: Corner Therapeutics and Infinitopes are two startups to watch.

Read the full article: PitchBook’s Q1 2024 Biopharma Report //

Source: https://pitchbook.com/news/reports/q1-2024-biopharma-report

Scroll to Top